-
Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Akolekar R, Ciobanu A, Zingler E, Syngelaki A, Nicolaides KH.
Am J Obstet Gynecol 2019;221:65.e1-65.e18. pdf -
Prediction of adverse perinatal outcome by cerebroplacental ratio in women undergoing induction of labor.
Fiolna M, Kostiv V, Anthoulakis C, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:473-480. pdf -
Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio.
Ciobanu A, Wright A, Syngelaki A, Wright D, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:465-472. pdf -
Two-stage approach for risk estimation of fetal trisomy 21 and other aneuploidies using computational intelligence systems.
Neocleous AC, Syngelaki A, Nicolaides KH, Schizas CN.
Ultrasound Obstet Gynecol 2018;51:503-508. pdf -
Intelligent Non-invasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset.
Neocleous A, Nicolaides K, Schizas C.
IEEE J Biomed Health Inform 2017;21:1271-1279. pdf -
First Trimester Noninvasive Prenatal Diagnosis: A Computational Intelligence Approach.
Neocleous AC, Nicolaides KH, Schizas CN.
IEEE J Biomed Health Inform 2016;20:1427-38. pdf -
Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tayyar A, Guerra L, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:689-97. pdf -
Meta-analysis of second-trimester markers for trisomy 21.
Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:247-61. -
Screening at 11-13+6 weeks' gestation.
Sonek JD, Nicolaides KH, Janku P.
Ceska Gynekol 2012;77:92-104. -
Nasal bone assessment in fetuses with trisomy 21 at 16-24 weeks of gestation by three-dimensional ultrasound.
Persico N, Molina F, Azumendi G, Fedele L, Nicolaides KH.
Prenat Diagn 2012;32:240-4. -
Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH.
Prenat Diagn 2011;31:7-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Additional first-trimester ultrasound markers.
Sonek J, Nicolaides K.
Clin Lab Med 2010;30:573-92. -
Nasal bone length in euploid fetuses at 16-24 weeks of gestation by three-dimensional ultrasound.
Persico N, Molina F, Borenstein M, Azumendi G, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:285-90. -
Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:259-64. -
Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation.
Persico N, Borenstein M, Molina F, Azumendi G, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:751-4. -
First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
Sonek J, Cicero S, Nicolaides K.
Am J Obstet Gynecol 2007;196:19. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Nasal bone assessment in prenatal screening for trisomy 21.
Sonek JD, Cicero S, Neiger R, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1219-30. -
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14.